Month: September 2018

Macrophage Pharma Announces Appointment of Leading International Scientific Advisory Board

10th September 2018, Windsor, UK: Macrophage Pharma Limited (‘MPL’), a company focused on the discovery and development of next-generation small molecules aiming to modulate immune responses to combat cancer and other diseases, announced today the formation of an international Scientific Advisory Board (SAB). The Scientific Advisory Board will closely work with management team as it … Continue reading “Macrophage Pharma Announces Appointment of Leading International Scientific Advisory Board”